Medical technology company Vision RT, received substantial new funding, including an investment of £250,000 from venture capitalist company The Capital Fund, which supports small and medium-sized companies in the Greater London area.

“The new funding will allow us to develop a direct representation in the U.S., a huge potential market for us, and push forward with the further development of GateCT and GateRT,” said Norman Smith, CEO of Vision RT.

According to the U.K. based-company, GateCT and GateRT track the breathing cycle via 3D surface imaging at up to 20 frames per second.